Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐ <scp>NMDA</scp> Receptor Encephalitis

Jian Wang, Mengjiao Li, Ping Kong

Open source

DOI
10.1002/acn3.70537
Published
2026-09-25
Container
Annals of Clinical and Translational Neurology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acn3.70537,
  title = {Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐
                    <scp>NMDA</scp>
                    Receptor Encephalitis},
  author = {Jian Wang and Mengjiao Li and Ping Kong},
  year = {2026},
  journal = {Annals of Clinical and Translational Neurology},
  doi = {10.1002/acn3.70537},
  url = {https://doi.org/10.1002/acn3.70537}
}

RIS

TY  - JOUR
TI  - Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐
                    <scp>NMDA</scp>
                    Receptor Encephalitis
AU  - Jian Wang
AU  - Mengjiao Li
AU  - Ping Kong
PY  - 2026
JO  - Annals of Clinical and Translational Neurology
DO  - 10.1002/acn3.70537
UR  - https://doi.org/10.1002/acn3.70537
ER  - 

APA

Wang, J., Li, M., & Kong, P. (2026). Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐ <scp>NMDA</scp> Receptor Encephalitis. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70537

Source records